SNDL
SNDL, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.37
+0.74%Aug 4, 2026, 20:30 UTC
SNDL Inc. announced the successful completion of an EU-GMP audit at its Atholville, New Brunswick cultivation facility on August 4, 2026.
Source:Jul 28, 2026, 10:55 UTC
SNDL accelerated its share repurchase program.
Jul 28, 2026, 10:55 UTC
SNDL reported its financial and operational results for the second quarter of 2026.
Jul 27, 2026, 15:48 UTC
SNDL Inc. completed the acquisition of certain assets of Surterra Holdings, Inc. (Parallel), a U.S. vertically integrated cannabis operator with operations in Florida, Texas and Massachusetts.